Despite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?
Despite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?
In this week’s Managed Care Cast, Elizabeth McGlynn, PhD, speaks with Patricia Salber, MD, MBA, of The Doctor Weighs In, about health care quality in the United States, quality measurement and incentives, what the United States can do to drive quality improvement, how social determinants fit into the picture, and more.
McGlynn serves as Kaiser Permanente Bernard J. Tyson School of Medicine’s Interim Senior Associate Dean for Research and Scholarships and as a professor. She is an internationally known expert on methods for evaluating the appropriateness and quality of health care delivery.
Listen above or through one of these podcast services:
Read more about health care quality in the United States:
Can Healthcare Quality Measures Benefit Patient Health?
Dr Kerin Adelson Discusses Evolution in Physician Response to Quality Care Initiatives
Can Accountable Care Divert the Sources of Hospitalization?
Healthcare Needs Bipartisan Support to Benefit Patients, Stabenow Says
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More